Dana Investment Advisors Inc. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 4.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,171 shares of the medical equipment provider’s stock after purchasing an additional 100 shares during the period. Dana Investment Advisors Inc.’s holdings in Intuitive Surgical were worth $1,133,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Bennett Selby Investments LP increased its holdings in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after purchasing an additional 17 shares during the last quarter. Onefund LLC grew its stake in shares of Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after acquiring an additional 18 shares in the last quarter. LVW Advisors LLC grew its stake in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its stake in shares of Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after acquiring an additional 19 shares in the last quarter. Finally, FSM Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after acquiring an additional 19 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research firms recently commented on ISRG. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Jefferies Financial Group upped their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Piper Sandler restated an “overweight” rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, Truist Financial upped their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.
Insider Transactions at Intuitive Surgical
In other news, CFO Jamie Samath sold 269 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 489 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02. Following the completion of the transaction, the senior vice president now owns 2,091 shares of the company’s stock, valued at approximately $1,114,879.38. This trade represents a 18.95 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,579 shares of company stock valued at $7,756,844. 0.90% of the stock is currently owned by insiders.
Intuitive Surgical Trading Down 3.8 %
ISRG stock opened at $518.26 on Friday. The stock has a market capitalization of $184.59 billion, a P/E ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a 50-day moving average price of $571.36 and a 200-day moving average price of $531.53.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Manufacturing Stocks Investing
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Best Stocks Under $10.00
- 3 Stocks to Buy While Others Stay on the Sidelines
- Best Stocks Under $5.00
- MarketBeat Week in Review – 03/03 – 03/07
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.